Mustang Bio’s first-of-a-kind CAR-T starts trialsUS biotech Mustang Bio says that an investigator-led trial of its CAR-T therapy for multiple myeloma – the Share XMustang Bio’s first-of-a-kind CAR-T starts trialshttps://pharmaphorum.com/news/mustang-bio-car-t-starts-trials/
